Status:
COMPLETED
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Schizophrenia
Agranulocytosis
Eligibility:
All Genders
18+ years
Brief Summary
Clozapine is a drug that requires regular and diligent hematological monitoring throughout its use. This follow-up is, in France, framed by a compulsory paper format of the blood count follow-up noteb...
Eligibility Criteria
Inclusion
- Population 1: all patients stabilized of Medical-Psychological Center (CMP) of St-Etienne treated with clozapine
- Population 2 : all psychiatrists of the Loire department
- Population 2 : all pharmacists of the Loire department
Exclusion
- NA
Key Trial Info
Start Date :
May 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 12 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06610500
Start Date
May 16 2023
End Date
September 12 2023
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint Etienne
Saint-Etienne, France, 42000